SCHEMBL315989

SCHEMBL315989

Cc1sc(-c2ccccc2)nc1CC(=O)NC1CCC(CCc2ccccc2)(N(C)C)CC1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.44
OPRL1 P41146 3/20 0.44
SIGMAR1 Q99720 1/20 0.40
PPARG P37231 3/20 0.39
PPARA Q07869 3/20 0.39
KMT2A Q03164 4/20 0.38
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 3/20 0.38
LMNA P02545 2/20 0.37
HTT P42858 2/20 0.37
EPHX2 P34913 1/20 0.37
MAPT P10636 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL316821 0.90 OPRM1 (0.46) OPRM1OPRL1SIGMAR1PPARGPPARA
SCHEMBL316610 0.85 OPRM1 (0.41) OPRM1OPRL1PPARGPPARAKMT2A
SCHEMBL5245600 0.85 KMT2A (0.44) PPARGKMT2AALDH1A1MEN1LMNA
SCHEMBL315932 0.84 LMNA (0.41) OPRM1OPRL1SIGMAR1PPARGPPARA
SCHEMBL315905 0.84 SIGMAR1 (0.43) OPRM1OPRL1SIGMAR1PPARGPPARA
SCHEMBL316431 0.84 KMT2A (0.42) OPRM1OPRL1SIGMAR1PPARGPPARA
SCHEMBL5245606 0.83 KMT2A (0.38) PPARGKMT2AALDH1A1MEN1LMNA
SCHEMBL315600 0.80 OPRM1 (0.48) OPRM1OPRL1SIGMAR1PPARGPPARA
SCHEMBL316418 0.76 HRH3 (0.41) OPRM1OPRL1SIGMAR1KMT2AALDH1A1
SCHEMBL5160129 0.76 OPRM1 (0.51) OPRM1OPRL1KMT2AMEN1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745009-B1 HETEROARYL SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2012-11-14 EP claimed
US-8093272-B2 Heteroaryl substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2012-01-10 US claimed
US-20070129369-A1 Heteroaryl substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-06-07 US claimed
EP-1745009-B1 HETEROARYL SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2012-11-14 EP disclosed
US-8093272-B2 Heteroaryl substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2012-01-10 US disclosed
US-20070129369-A1 Heteroaryl substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129369-A1 Heteroaryl substituted cyclohexyl-1,4-diamine compounds DDC, DPYD, PKD1 OPRM1 2315/4885OPRL1 2457/4885SIGMAR1 2685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.